إسرائيل - العبرية - Ministry of Health

romat ltd - enrofloxacin - תמיסה (פומי) - enrofloxacin 100 mg / 1 ml

إسرائيل - العبرية - Ministry of Health

romat ltd - aspartic acid; cyanocobalamin; d, l-acetylmethionine; fructose; glutamic acid; glycine; l- citrulline; l- lysine as hydrochloride; l- ornithine as hydrochloride; l-arginine; l-carnitine as hydrochloride; pyridoxine (vit b6) hydrochloride; sorbitol; thioctic acid - תמיסה להזרקה - thioctic acid 0.2 mg/ml; cyanocobalamin 0.03 mg/ml; glycine 1.5 mg/ml; aspartic acid 1.5 mg/ml; glutamic acid 1.5 mg/ml; fructose 50 mg/ml; sorbitol 80 mg/ml; pyridoxine (vit b6) hydrochloride 0.15 mg/ml; l- ornithine as hydrochloride 1.20 mg/ml; l- lysine as hydrochloride 0.50 mg/ml; l- citrulline 1.20 mg/ml; l-carnitine as hydrochloride 5.00 mg/ml; l-arginine 2.40 mg/ml; d, l-acetylmethionine 20.00 mg/ml

إسرائيل - العبرية - Ministry of Health

romat ltd - lincomycin hydrochloride; spectinomycin hydrochloride - תמיסה להזרקה - spectinomycin hydrochloride 150 mg/ml; lincomycin hydrochloride 56.7 mg/ml

إسرائيل - العبرية - Ministry of Health

romat ltd - rifaximine - טבליה - rifaximine 300 mg

إسرائيل - العبرية - Ministry of Health

romat ltd - rifaximine - קצף - rifaximine 0.75 %w/w

إسرائيل - العبرية - Ministry of Health

romat ltd - ketoprofen - תמיסה להזרקה - ketoprofen 100 mg / 1 ml

إسرائيل - العبرية - Ministry of Health

romat ltd - marbofloxacin - תמיסה להזרקה - marbofloxacin 100 mg / 1 ml

إسرائيل - العبرية - Ministry of Health

romat ltd - marbofloxacin - תמיסה להזרקה - marbofloxacin 20 mg / 1 ml

إسرائيل - العبرية - Ministry of Health

romat ltd - cefquinome as sulfate - תרחיף להזרקה - cefquinome as sulfate 25 mg / 1 ml

إسرائيل - العبرية - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.